tolododekin alfa: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Phase breakdown

Conditions being studied

Recruiting trials involving tolododekin alfa

• A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer
  NCT07027514 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 11 locations
• Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
  NCT06171750 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations

Common questions

How many recruiting trials involve tolododekin alfa?

2 recruiting trials across 10 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.